The Now Corporation
- Company typePublic
- Founded2003
- HeadquartersOakland Park, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
The Now Corporation firmographics
Firmographics- Name
- The Now Corporation
- Legal name
- Ubuy International FZE
- Website
- https://thenowcorp.net
- Company type
- Public
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Where The Now Corporation is headquartered
LocationHeadquarters
- HQ city
- Oakland Park
- HQ country
- United States
- HQ region
- North America
Markets served
The Now Corporation business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations
The Now Corporation product offering
Product offeringCore offering
The Now Corporation is a biopharmaceutical research company that develops cannabis-derived therapeutic products. The company conducts research to formulate and develop pharmaceutical-grade therapeutic candidates derived from cannabis, targeting medical applications. It operates a small team (11-50 employees) and is publicly traded on OTC Pink under the ticker NWPN.
Differentiator
Problem solved
Functional benefit
Products and services
- Cannabis-derived therapeutic products Research and development of cannabis-derived therapeutic candidates intended for pharmaceutical and medical applications; targeted at pharmaceutical companies, drug developers, and healthcare partners seeking novel therapeutic compounds.
Companies that use The Now Corporation
Customer profileIdeal customer profiles1 record
The Now Corporation technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
The Now Corporation partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Incued Fintech PlatformminorThe Now Corporation acquired Incued Fintech Platform. This appears to be an acquisition transaction. Limited details available about the nature of the fintech platform or integration plans.
Recent moves2 records
Expansion highlights3 records
The Now Corporation competitors and assessment
Company assessmentDirect peers
- Jazz Pharmaceuticals (GW Pharmaceuticals): Acquired GW Pharmaceuticals in 2021, originator of cannabis-derived Epidiolex (CBD) and Sativex. Most directly comparable cannabis-therapeutic developer with FDA-approved cannabinoid assets, GMP manufacturing, and global commercial reach - the bar The Now Corporation would need to clear in cannabis biopharma.
- InMed Pharmaceuticals: Biopharmaceutical company developing cannabinoid-based prescription therapeutics via biosynthesis and rare-disease pipeline. Comparable as a small-cap, R&D-driven cannabis biopharma pursuing regulated drug pathways.
- Zynerba Pharmaceuticals: Clinical-stage developer of pharmaceutically-produced transdermal cannabinoid therapeutics for orphan neurology and psychiatry indications. Closely comparable as a small-cap, pipeline-focused cannabinoid biopharmaceutical company targeting regulated drug approvals.
- Cardiol Therapeutics: Clinical-stage biotech developing cannabidiol-based therapies for inflammatory heart disease. Comparable small-cap, publicly-listed cannabinoid biopharmaceutical with a similar regulatory and capital-raising profile to The Now Corporation's stated focus.
Emerging players
- Medical Marijuana Inc. U.S. publicly-listed holding company with hemp-derived CBD wellness products and a subsidiary (Kannalife) exploring cannabinoid therapeutics. Comparable on small-cap, publicly-listed cannabis-derivative profile and over-the-counter distribution.
- Corbus Pharmaceuticals: Clinical-stage company with prior cannabinoid pipeline exposure (now pivoted to precision oncology). Comparable on small-cap clinical-stage cannabinoid biopharma profile; illustrates the capital-intensive, high-failure-rate trajectory for cannabinoid therapeutic development.
Broad incumbents
- Canopy Growth: Global cannabis operator with historical biopharmaceutical ambitions (Spectrum Therapeutics) and pending/acquired U.S. THC entry vehicles. Broad incumbent setting regulated-market standards for pharmaceutical-grade cannabis products.
- Cronos Group: Global cannabis operator historically backed by Altria, pursuing cannabinoid-based product innovation including biopharmaceutical R&D. Broad incumbent with capital and GMP infrastructure that a microcap cannabis biopharma would benchmark against.
- Aurora Cannabis: Large Canadian-licensed cannabis producer with medical, consumer, and wholesale operations across multiple jurisdictions. Comparable on cannabis end-market positioning, though predominantly production/distribution rather than pure biopharma.
- Tilray Brands: Large vertically-integrated cannabis operator with medical-cannabis, GMP manufacturing, and biopharmaceutical-adjacent capabilities. Broad incumbent illustrating the operational scale and capital base against which a microcap cannabis-biopharma claim would be measured.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
The Now Corporation social profiles
Digital presenceThe Now Corporation financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Now Corporation leadership team
Management profileNumber of profiles
Profiles3 records
The Now Corporation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Now Corporation M&A and investment
M&A and investmentM&A1 record
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Now Corporation
What does The Now Corporation do?
The Now Corporation is a biopharmaceutical research company that develops cannabis-derived therapeutic products. The company conducts research to formulate and develop pharmaceutical-grade therapeutic candidates derived from cannabis, targeting medical applications. It operates a small team (11-50 employees) and is publicly traded on OTC Pink under the ticker NWPN.
Is The Now Corporation a public or private company?
The Now Corporation is a public company. It is classified as public and is currently operating.
When was The Now Corporation founded?
The Now Corporation was founded in 2003. It employs 11 to 50 people.
Where is The Now Corporation based?
The Now Corporation is headquartered in Oakland Park, United States, in the North America region.
Who are The Now Corporation's main competitors?
Direct peers on record are Jazz Pharmaceuticals (GW Pharmaceuticals), InMed Pharmaceuticals, Zynerba Pharmaceuticals and Cardiol Therapeutics. Emerging players are Medical Marijuana Inc. and Corbus Pharmaceuticals. Broad incumbents are Canopy Growth, Cronos Group, Aurora Cannabis and Tilray Brands.
Does The Now Corporation have an API?
No public API is recorded for The Now Corporation.